Mankind Pharma Limited

NSE: MANKIND

Healthcare Healthcare

₹2,394

+0.59%EOD · 19 Aug

Mankind Pharma Limited is a listed Healthcare company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹98,871 Cr

52W Range

₹2674 / ₹1910

Volume

370K

38.0% delivery

1Y Return

-8.2%

P/E Ratio

49.0

P/B Ratio

6.1

ROE

12.4%

Debt / Equity

38.11

Peers in Healthcare

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Mankind Pharma Limited(this stock)	₹2,394	₹98,871 Cr	49.0	6.1	12.4%	0.08%
Divi's Laboratories LimitedDIVISLAB	₹8,560	₹2.27 L Cr	87.5	13.4	16.2%	0.35%
Torrent Pharmaceuticals LimitedTORNTPHARM	₹5,013	₹1.91 L Cr	76.9	19.5	17.0%	0.79%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	₹8,750	₹1.26 L Cr	61.4	13.5	21.5%	0.23%
Zydus Lifesciences LimitedZYDUSLIFE	₹1,104.5	₹1.10 L Cr	25.3	4.2	18.3%	0.09%
Laurus Labs LimitedLAURUSLABS	₹1,801.8	₹97,353 Cr	88.6	18.2	17.7%	0.13%
Max Healthcare Institute LimitedMAXHEALTH	₹997	₹97,036 Cr	67.7	9.1	14.3%	0.20%
Aurobindo Pharma LimitedAUROPHARMA	₹1,624.5	₹93,470 Cr	25.3	2.5	9.9%	0.24%
Aster DM Healthcare LimitedASTERDM	₹800.2	₹69,751 Cr	133.1	9.3	10.1%	0.48%

Technical Indicators

Full analysis · objective math, not advice

Returns

+0.6%

-0.4%

-4.5%

+2.5%

+7.5%

-8.2%

Weinstein Stage

Stage 2 — Advancing (uptrend)

RSI (14)

32 Neutral

Trend Template

5/7moderate

RS vs Nifty (3M)

-0.5pp

Moving Averages (price vs MA)

20-DMA

₹2456

below

50-DMA

₹2493

below

150-DMA

₹2316

above

200-DMA

₹2283

above

From 52W High

-10.5%

From 52W Low

+25.4%

Support (20D)

₹2363

Resistance (20D)

₹2642

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+13.0% CAGR

Up 7 of last 8 years

Earnings Quality

Fully cash-backed

OCF / Net Profit = 1.35x · 9/9 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.